☰

Elodie Lainey - Publications

Affiliations: 
University Paris 11 
Area:
Myelodysplasia, Acute myeloid Leukemia, Azacytidine, Erlotinib, Apoptosis
Tree Info Similar researchers PubMed Report error

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Philippot Q, Kannengiesser C, Debray MP, Gauvain C, Ba I, Vieri M, Gondouin A, Naccache JM, Reynaud-Gaubert M, Uzunhan Y, Bondue B, Israël-Biet D, Dieudé P, Fourrage C, Lainey E, et al. Interstitial lung diseases associated with mutations of poly(A)-specific ribonuclease: A multicentre retrospective study. Respirology (Carlton, Vic.). 27: 226-235. PMID 34981600 DOI: 10.1111/resp.14195  0.56
2019 Caye A, Rouault-Pierre K, Strullu M, Lainey E, Abarrategi A, Fenneteau O, Arfeuille C, Osman J, Cassinat B, Pereira S, Anjos-Afonso F, Currie E, Ariza-McNaughton L, Barlogis V, Dalle JH, et al. Despite mutation acquisition in hematopoietic stem cells, JMML-propagating cells are not always restricted to this compartment. Leukemia. PMID 31776464 DOI: 10.1038/S41375-019-0662-Y  0.354
2016 Lainey E, Caye-Eude A, Broseus L, Clappier E, Cuccuini W, Leschi C, Fenneteau O, Mullaert J, Chaye A, Emam A, Brethon B, Leblanc T, Baruchel A, Cave H. Immunophenotypic Profiling of Childhood B-Cell Precursor Acute Lymphoblastic Helps Identifying Genetic Subtypes, Including Recently Identified Ones Blood. 128: 2910-2910. DOI: 10.1182/Blood.V128.22.2910.2910  0.312
2013 Lainey E, Wolfromm A, Sukkurwala AQ, Micol JB, Fenaux P, Galluzzi L, Kepp O, Kroemer G. EGFR inhibitors exacerbate differentiation and cell cycle arrest induced by retinoic acid and vitamin D3 in acute myeloid leukemia cells. Cell Cycle (Georgetown, Tex.). 12: 2978-91. PMID 23974111 DOI: 10.4161/Cc.26016  0.783
2013 Lainey E, Wolfromm A, Marie N, Enot D, Scoazec M, Bouteloup C, Leroy C, Micol JB, De Botton S, Galluzzi L, Fenaux P, Kroemer G. Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia. Oncogene. 32: 4331-42. PMID 23085751 DOI: 10.1038/Onc.2012.469  0.687
2012 Lainey E, Sébert M, Thépot S, Scoazec M, Bouteloup C, Leroy C, De Botton S, Galluzzi L, Fenaux P, Kroemer G. Erlotinib antagonizes ABC transporters in acute myeloid leukemia. Cell Cycle (Georgetown, Tex.). 11: 4079-92. PMID 23095522 DOI: 10.4161/Cc.22382  0.669
2012 Balabanian K, Brotin E, Biajoux V, Bouchet-Delbos L, Lainey E, Fenneteau O, Bonnet D, Fiette L, Emilie D, Bachelerie F. Proper desensitization of CXCR4 is required for lymphocyte development and peripheral compartmentalization in mice. Blood. 119: 5722-30. PMID 22438253 DOI: 10.1182/Blood-2012-01-403378  0.307
2011 Tailler M, Senovilla L, Lainey E, Thépot S, Métivier D, Sébert M, Baud V, Billot K, Fenaux P, Galluzzi L, Boehrer S, Kroemer G, Kepp O. Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemia. Oncogene. 31: 3536-46. PMID 22105358 DOI: 10.1038/Onc.2011.521  0.775
2011 Boehrer S, Galluzzi L, Lainey E, Bouteloup C, Tailler M, Harper F, Pierron G, Adès L, Thépot S, Sébert M, Gardin C, de Botton S, Fenaux P, Kroemer G. Erlotinib antagonizes constitutive activation of SRC family kinases and mTOR in acute myeloid leukemia. Cell Cycle (Georgetown, Tex.). 10: 3168-75. PMID 21897118 DOI: 10.4161/Cc.10.18.16599  0.77
2011 Boehrer S, Lainey E, Kroemer G. Coordinated epigenetic regulation of autophagy and apoptosis. Cell Cycle (Georgetown, Tex.). 10: 2832-3. PMID 21869599 DOI: 10.4161/Cc.10.17.16575  0.437
2011 Lainey E, Thépot S, Bouteloup C, Sébert M, Adès L, Tailler M, Gardin C, de Botton S, Baruchel A, Fenaux P, Kroemer G, Boehrer S. Tyrosine kinase inhibitors for the treatment of acute myeloid leukemia: delineation of anti-leukemic mechanisms of action. Biochemical Pharmacology. 82: 1457-66. PMID 21664897 DOI: 10.1016/J.Bcp.2011.05.011  0.753
2011 Thépot S, Lainey E, Cluzeau T, Sébert M, Leroy C, Adès L, Tailler M, Galluzzi L, Baran-Marszak F, Roudot H, Eclache V, Gardin C, de Botton S, Auberger P, Fenaux P, et al. Hypomethylating agents reactivate FOXO3A in acute myeloid leukemia. Cell Cycle (Georgetown, Tex.). 10: 2323-30. PMID 21654193 DOI: 10.4161/Cc.10.14.16399  0.765
2011 Sebert M, Lainey E, Lepelley P, Thepot S, Tailler M, Gardin C, Kroemer G, Boehrer S, Ades L, Fenaux P. Expression and Function of the P-Glycoprotein (P-gp) In Myelodysplastic Syndromes (MDS) Treated with Azacytidine (AZA) Blood. 118: 5028-5028. DOI: 10.1182/Blood.V118.21.5028.5028  0.704
2011 Lainey E, Sebert M, Bouteloup C, Leroy C, Thepot S, Tailler M, Ades L, Gardin C, Kroemer G, Fenaux P, Boehrer S. Potentiation of Apoptosis in MDS/AML by Combination of Azacitidine and the EGFR-Tyrosine Kinase Inhibitor (TKI) erlotinib Blood. 118: 2790-2790. DOI: 10.1182/Blood.V118.21.2790.2790  0.773
2011 Lainey E, Sebert M, Bouteloup C, Leroy C, Thepot S, Tailler M, Ades L, Gardin C, Kroemer G, Fenaux P, Boehrer S. Erlotinib Antagonizes Efflux Via ABC Transporters and Decreases P-Gp Cell Surface Expression by Inhibiting SRC Kinase and mTOR Pathways in Acute Myeloid Leukemia (AML) Blood. 118: 2564-2564. DOI: 10.1182/Blood.V118.21.2564.2564  0.758
2011 Thepot S, Lainey E, Sebert M, Tailler M, Leroy C, Bouteloup C, Ades L, Gardin C, Fenaux P, Kroemer G, Boehrer S. 189 Hypomethylating agents induce apoptosis and cell cycle arrest with a concomitant activation of p53-dependent signalling pathways and Foxo3a activation Leukemia Research. 35: S74-S75. DOI: 10.1016/S0145-2126(11)70191-6  0.74
2010 Billard M, Lainey E, Armoogum P, Alberti C, Fenneteau O, Da Costa L. Evaluation of the CellaVision DM automated microscope in pediatrics. International Journal of Laboratory Hematology. 32: 530-8. PMID 20132350 DOI: 10.1111/J.1751-553X.2009.01219.X  0.325
2010 Chapiro E, Russell L, Lainey E, Kaltenbach S, Ragu C, Della-Valle V, Hanssens K, MacIntyre EA, Radford-Weiss I, Delabesse E, Cavé H, Mercher T, Harrison CJ, Nguyen-Khac F, Dubreuil P, et al. Activating mutation in the TSLPR gene in B-cell precursor lymphoblastic leukemia Leukemia. 24: 642-645. PMID 19907440 DOI: 10.1038/Leu.2009.231  0.321
2010 Lainey E, Sebert M, Thepot S, Tailler M, Ades L, Gardin C, Kroemer G, Fenaux P, Boehrer S. Erlotinib Increases Efficacy of 5-Azacitidine (AZA) by Inhibiting Drug Efflux Via ABC-Transporters Blood. 116: 974-974. DOI: 10.1182/Blood.V116.21.974.974  0.771
2010 Thepot S, Lainey E, Sebert M, Ades L, Gardin C, Fenaux P, Kroemer G, Boehrer S. Hypomethylating Agents Correct Subcellular Localization of FOXO3a and (re)Establish Expression of Its Transcriptional Targets In AML and MDS- Cells Blood. 116: 2173-2173. DOI: 10.1182/Blood.V116.21.2173.2173  0.614
2010 Sebert M, Lainey E, Thepot S, Tailler M, Ades L, Gardin C, Fenaux P, Kroemer G, Boehrer S. Erlotinib Inhibits ABC Transporters of AML Progenitors with Stem Cell Features and Increases Chemosensitivity to Current AML Drugs Blood. 116: 2163-2163. DOI: 10.1182/Blood.V116.21.2163.2163  0.721
Show low-probability matches.